Non-nucleoside reverse transcriptase inhibitors

Details Non-nucleoside reverse transcriptase inhibitors Non-nucleoside reverse transcriptase inhibitors

2007-01-23

2007-01-23

McKane, Joseph K. (Department: 1626)

Organic compounds -- part of the class 532-570 series

Organic compounds

Nitriles

C564S086000

Reexamination Certificate

active

11112591

ABSTRACT:
The present invention provides compounds for treating or preventing an HIV infection, or treating AIDS or ARC comprising administering a compound according to formula I where Ar, R1—R5, R7a, R7b, R7c, R8—R10, X1, X2m, n, o and p are as defined herein

REFERENCES:
patent: 6028080 (2000-02-01), Ackermann et al.
patent: 6710205 (2004-03-01), Tani et al.
patent: 2003/0114435 (2003-06-01), Tani et al.
patent: 2003/0187068 (2003-10-01), Miyachi et al.
patent: 2003/0220241 (2003-11-01), Defeo-Jones et al.
patent: 2-218654 (1990-08-01), None
patent: WO 93/15043 (1993-08-01), None
patent: WO 96/22990 (1996-08-01), None
patent: WO 97/26244 (1997-07-01), None
patent: WO 98/50346 (1998-11-01), None
patent: WO 99/17777 (1999-04-01), None
patent: WO 99/55663 (1999-11-01), None
patent: WO 99/65874 (1999-12-01), None
patent: WO 00/64876 (2000-11-01), None
patent: WO 01/17982 (2001-03-01), None
patent: WO 01/19788 (2001-03-01), None
patent: WO 01/21596 (2001-03-01), None
patent: WO 01/64642 (2001-09-01), None
patent: WO 02/057236 (2002-07-01), None
patent: WO 02/070494 (2002-09-01), None
W. Buckheit, Jr., Non-nucleoside reverse transcriptase inhibitors: perspectives for novel therapeutic compounds and strategies for treatment of HIV infection,Expert Opin. Investig. Drugs 2001 10(8):1423-1442.
R. W. Carling et al., 4-Substituted-3-phenylquinolin-2(1H)-ones: Acidic and Nonacidic Glycine Site N-Methyl-D-aspartate Antagonists with in Vivo Activity,J. Med. Chem., 1997 40:754-765.
J. H. Chan et al., Novel Benzophenones as Non-nucleoside Reverse Transcriptase Inhibitors of HIV-1,J. Med Chem. 2004 47(5):1175-1182.
E. De Clercq,New Developments in Anti-HIV Chemotherap. Curr. Med. Chem. 2001 8:1543-1572.
M. C. Iles et al., Carbonic Anhydrase Inhibitors. Inhibition of Tumor-Associated Isozyme IX by Halogenosulfanilamide and Halogenophenylaminobenzolamide Derivatives,J. Med. Chem. 2003 46(11):2187-2196.
A. Kreimeyer et al., Evaluation and Biological Properties of Reactive Ligands for the Mapping of the Glycine Site on the N-Methyl-D-aspartate (NMDA) Receptor,J. Med. Chem. 1999 42:4394-4404.
J. J. Kulagowski et al., 3′-(Arylmethyl)- and 3′-(Aryloxy)-3-phenyl-4-hydroxyquinolin- 2(1H)-ones: Orally Active Antagonists of the Glycine Site on the NMDA Receptor,J. Med. Chem. 1994 37:1402-1405.
M. Rowley et al., Effect of Plasma Protein Binding onin VivoActivity and Brain Penetration of Glycine/NMDA Receptor Antagonists,J. Med. Chem. 1997 40:4053-4068.
P. G. Wyatt et al., Benzophenone Derivatives: A Novel Series of Potent and Selective Inhibitors of Human Immunodeficiency Virus Type 1 Reverse Transcriptase,J. Med. Chem. 1995 38(10):1657-1665).

Affiliated with

Also associated with

Rating

Non-nucleoside reverse transcriptase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Non-nucleoside reverse transcriptase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Non-nucleoside reverse transcriptase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3768272